Immusoft to Present Data Highlighting Positive Results from the World’s First Engineered B Cell in a Human Clinical Trial at ASGCT 2026

AI Briefing

• – Immusoft presents data on engineered B cell therapy at ASGCT 2026.
• – Company's clinical-stage biotechnology pioneer, Scott McIvor, to present recent clinical data in Boston.
• – Data highlights positive results from the world's first engineered B cell in a human clinical trial.